• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov28
Lexaria Bioscience released FY2025 earnings on November 27 (EST), actual revenue USD 705.92 K (forecast USD 669 K), actual EPS USD -0.6612 (forecast USD -0.6766)
04:00
Lexaria Bioscience released FY2025 Q4 earnings on November 27 EST, actual revenue USD 174 K (forecast USD 137 K), actual EPS USD -0.1377 (forecast USD -0.1566)
04:00
Jul15
Lexaria Bioscience released FY2025 9 Months Earnings on July 14 (EST), actual revenue USD 531.92K, actual EPS USD -0.5242
03:00
Lexaria Bioscience released FY2025 Q3 earnings on July 14 (EST), actual revenue USD 174 K (forecast USD 137 K), actual EPS USD -0.207 (forecast USD -0.145)
03:00
Jun23
Lexaria Secures Patent for Epilepsy Treatment and Nicotine Delivery
13:15
Jun12
Lexaria Bioscience Corp Adds Expenses to Clinical Study
21:00

Schedules & Filings

Schedules
Filings
Nov27
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 174 K, Net Income -2.696 M, EPS -0.1377

Jul14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 174 K, Net Income -3.789 M, EPS -0.207

Apr14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 174 K, Net Income -2.713 M, EPS -0.1549

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More